These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3148787)

  • 1. [Combination therapy with insulin/sulfonylurea in the long-term therapy of type II diabetes following "secondary failure"].
    Lotz N; Bachmann W; Ladik T; Mehnert H
    Klin Wochenschr; 1988 Nov; 66(21):1079-84. PubMed ID: 3148787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH; Masoodi SR; Laway BA; Wani AI; Bashir MI
    J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.
    Landstedt-Hallin L; Adamson U; Arner P; Bolinder J; Lins PE
    Diabetes Care; 1995 Aug; 18(8):1183-6. PubMed ID: 7587856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin-sulfonylurea combination therapy in secondary therapy failure with sulfonylurea compounds. Randomized study between evening and morning intermediary insulin administration using the Novo Pen semi-automatic insulin injector].
    Stradner F; Pieber T; Toplak H; Schreiber U; Pfeiffer KP
    Schweiz Med Wochenschr; 1990 Jul; 120(27-28):989-94. PubMed ID: 2115686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination therapy with insulin and sulfonylurea in secondary failure of sulfonylurea therapy].
    Sachse G; Mäser E; Federlin K
    Dtsch Med Wochenschr; 1984 Mar; 109(11):419-21. PubMed ID: 6421560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term intensive insulin therapy as a method of overcoming secondary failure of sulfonylureas in patients with type 2 diabetes (non-insulin-dependent)].
    Jedynasty K; Kasperska-Czyzykowa T; Stepień K; Nowaczyk R
    Pol Arch Med Wewn; 1998 Jun; 99(6):442-51. PubMed ID: 10085698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy with insulin and sulfonylurea compounds in type II diabetes mellitus--long-term results].
    Winkler F; Studlar M
    Wien Klin Wochenschr; 1992; 104(5):134-6. PubMed ID: 1574905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.
    Hermann LS; Scherstén B; Bitzén PO; Kjellström T; Lindgärde F; Melander A
    Diabetes Care; 1994 Oct; 17(10):1100-9. PubMed ID: 7821128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes].
    Lotz N
    Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.
    Mohan V; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1990 Aug; 38(8):537-41. PubMed ID: 2123183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-insulin-dependent diabetics with secondary failure: insulin therapy at bedtime combined with glibenclamide].
    Maiz A; Arteaga A; Klaassen J; Velasco N; Borkosky M; Jiménez M; Acosta AM
    Rev Med Chil; 1993 Oct; 121(10):1135-41. PubMed ID: 8191117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend.
    Peters AL; Davidson MB
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2423-7. PubMed ID: 8675555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term effect of combination glibenclamide-insulin treatment in the secondary failure of sulfonylurea therapy--results of a one-year double blind study].
    Lundershausen R; Orban S; Pissarek D; Panzram G
    Wien Klin Wochenschr; 1987 Sep; 99(17):603-8. PubMed ID: 3118579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.
    Bieger WP; Dlugosch R; Rettenmeier A; Holler HD; Bert H; Schwarz W; Fiehn W; Merkt J; Weicker H
    Klin Wochenschr; 1984 Jul; 62(13):631-9. PubMed ID: 6434794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM.
    Groop LC; Widén E; Ekstrand A; Saloranta C; Franssila-Kallunki A; Schalin-Jäntti C; Eriksson JG
    Diabetes Care; 1992 Jul; 15(7):831-4. PubMed ID: 1516500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of combined treatment with glibenclamide and insulin in secondary sulfonylurea failure. A controlled multicenter double-blind clinical trial].
    Bachmann W; Lotz N; Mehnert H; Rosak C; Schöffling K
    Dtsch Med Wochenschr; 1988 Apr; 113(16):631-6. PubMed ID: 3129273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.